Onaolapo AY, Onaolapo OJ
They can develop anywhere but are most common in areas exposed to the sun, friction, or injury
Both are accessible from the following method: The fastest way to launch a recording session (recommended): Once selected recording will start with a 4-click count-in - 4, 3, 2, 1

The 2025 KFF Employer Health Benefits Survey reveals a significant shift in how larger employers approach GLP-1 coverage for weight loss: Coverage by employer size: 5,000+ employees: 43% now cover GLP-1s for weight loss (up from 28% in 2024) 1,000-4,999 employees: 30% cover GLP-1s for weight loss 200-999 employees: 16% cover GLP-1s for weight loss The cost reality: 59% of very large employers (5,000+) say GLP-1 use for weight loss was higher than expected 66% of these employers say GLP-1s had a "significant" impact on prescription drug spending One employer reported GLP-1s went from their 32nd highest drug cost to their #1 drug cost in a single year Among employers with 200+ workers that don't currently cover GLP-1s for weight loss, only 1% say they're "very likely" to begin coverage in the next 12 months, while 67% say they're "not likely" to add coverage
Follow your treatment plan if you have diabetes or other medical conditions that may increase your risk of cataract
Dev Med Child Neurol 58(10):10921094